[
    [
        {
            "time": "",
            "original_text": "股下跌，‘三高’茅台却直奔3万亿！涨到券商来不及改目标价，A股‘逆行者’还能飞多高？",
            "features": {
                "keywords": [
                    "茅台",
                    "三高",
                    "券商",
                    "目标价",
                    "A股",
                    "逆行者"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "股下跌，‘三高’茅台却直奔3万亿！涨到券商来不及改目标价，A股‘逆行者’还能飞多高？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "从叶氏化工集团(00408)分拆的洋紫荆创业板IPO获受理",
            "features": {
                "keywords": [
                    "叶氏化工",
                    "洋紫荆",
                    "创业板",
                    "IPO",
                    "分拆"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "从叶氏化工集团(00408)分拆的洋紫荆创业板IPO获受理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药行业重大事项点评：第四批带量采购拟中标结果产生 降价幅度符合预期",
            "features": {
                "keywords": [
                    "医药",
                    "带量采购",
                    "中标",
                    "降价",
                    "预期"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业重大事项点评：第四批带量采购拟中标结果产生 降价幅度符合预期",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]